MedTrace Logo

Radiofrequency of Breast Cancers in Non Surgical Patients

NCT00210223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-10-01

Study results available
· View outcomes & findings →

Summary

To determine the efficacy and tolerance of ultrasonography (US)-guided percutaneous radiofrequency (RF) ablation with endocrine therapy in elderly patients with breast cancer who decline or are not candidates for surgery.

Conditions

Interventions

PROCEDURE

ultrasonography (US)-guided percutaneous radiofrequency (RF) ablation with endocrine therapy

ultrasonography (US)-guided percutaneous radiofrequency (RF) ablation with endocrine therapy

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Fabienne VALENTIN, MD · Institut Bergonié

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2010-12-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210223 on ClinicalTrials.gov